Eosinophil Degranulation Is More Important than Eosinophilia in Identifying Asthma in Chronic Cough

References

• Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel FB. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323(15):1033–1039.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145(6):1469–1476.
   PubMedGoogle Scholar
• Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56(4):985–1003.
   PubMed Web of Science ®Google Scholar
• Leckie M, Brinke A, Khan J, Diamant Z, O’Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356(9248):2144–2148.
   PubMed Web of Science ®Google Scholar
• Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil’s role remains uncertain as anti–interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003; 167(2):199–204.
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ, Pavord ID. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360(10):973–984.
   PubMed Web of Science ®Google Scholar
• Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE, O’Byrne PM. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009; 360(10):985–993.
   PubMed Web of Science ®Google Scholar
• Moqbel R, Lace P, Adamko DJ, Odemuyiwa SO. Allergy: Principles & Practice. Chapter 18, Biology of Eosinophils. St. Louis, MO: Mosby, 2008:295–310.
   Google Scholar
• Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999; 29(9):1172–1186.
   PubMed Web of Science ®Google Scholar
• Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, Gleich GJ, Dolovich J, Hargreave FE. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154(2 Pt 1):308–317.
   PubMed Web of Science ®Google Scholar
• Boulet LP, Milot J, Boutet M, St Georges F, Laviolette M. Airway inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med 1994; 149(2 Pt 1):482–489.
   PubMedGoogle Scholar
• Carney IK, Gibson PG, Murree-Allen K, Saltos N, Olson LG, Hensley MJ. A systematic evaluation of mechanisms in chronic cough. Am J Respir Crit Care Med 1997; 156(1):211–216.
   PubMedGoogle Scholar
• Irwin RS, Rosen MJ, Braman SS. Cough: a comprehensive review. Arch Intern Med 1977; 137:1186–1191.
   PubMedGoogle Scholar
• Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147(5):1126–1131.
   PubMed Web of Science ®Google Scholar
• Belda J, Leigh R, Parameswaran K, O’Byrne PM, Sears MR, Hargreave FE. Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161(2 Pt 1):475–478.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1(8651):1346–1348.
   PubMed Web of Science ®Google Scholar
• Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 1995; 25(2):127–132.
   PubMed Web of Science ®Google Scholar
• McGarvey LP, Forsythe P, Heaney LG, MacMahon J, Ennis M. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J 1999; 13(1):59–65.
   PubMedGoogle Scholar
• Lacoste JY, Bousquet J, Chanez P, Van Vyve T, Simony-Lafontaine J, Lequeu N, Vic P, Enander I, Godard P, Michel FB. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993; 92(4):537–548.
   PubMed Web of Science ®Google Scholar
• Wenzel SE, Szefler SJ, Leung DY, Sloan SI, Rex MD, Martin RJ. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose corticosteroids. Am J Respir Crit Care Med 1997; 156(3 Pt 1):737–743.
   PubMed Web of Science ®Google Scholar
• Cai Y, Carty K, Henry RL, Gibson PG. Persistence of sputum eosinophilia in children with controlled asthma compared with healthy children. Eur Respir J 1998; 11(4):848–853.
   PubMedGoogle Scholar
• Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, Chu HW. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160(3):1001–1008.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52(6):498–501.
   PubMed Web of Science ®Google Scholar
• Turner MO, Hussack P, Sears MR, Dolovich J, Hargreave FE. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50(10):1057–1061.
   PubMed Web of Science ®Google Scholar
• Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353(9171):2213–2214.
   PubMed Web of Science ®Google Scholar
• Monteseirin J, Bonilla I, Camacho J, Conde J, Sobrino F. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol 2001; 107(4):623–626.
   PubMedGoogle Scholar
• Niimi A, Torrego A, Nicholson AG, Cosio BG, Oates TB, Chung KF. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol 2005; 116(3):565–570.
   PubMed Web of Science ®Google Scholar
• Gleich GJ, Adolphson CR. Interleukin-5: From Molecule to Drug Target for Asthma, (Lung Biology in Health and Disease). Chapter 1, The Eosinophil and Bronchial Asthma: Evidence for a Critical Role of Eosinophils in Pathophysiology. New York: Marcel Dekker, Inc., 1999:1–37.
   Google Scholar
• Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 1995; 154(9):4749–4758.
   PubMed Web of Science ®Google Scholar
• Gundel RH, Letts LG, Gleich GJ. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest 1991; 87(4):1470–1473.
   PubMed Web of Science ®Google Scholar
• Kikuchi I, Kikuchi S, Kobayashi T, Hagiwara K, Sakamoto Y, Kanazawa M, Nagata M. Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils. Am J Respir Cell Mol Biol 2006; 34(6):760–765.
   PubMedGoogle Scholar
• Sedgwick JB, Vrtis RF, Jansen KJ, Kita H, Bartemes K, Busse WW. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin. J Allergy Clin Immunol 2004; 114(3):568–574.
   PubMedGoogle Scholar
• Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, Kobayashi Y. Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 2001; 26(1):79–82.
   PubMedGoogle Scholar
• Kim CK, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010; 47(5):568–573.
   PubMed Web of Science ®Google Scholar
• Park SW, Kim DJ, Chang HS, Park SJ, Lee YM, Park JS, Chung IY, Lee JH, Park CS. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol 2003; 131(4):283–290.
   PubMedGoogle Scholar
• Oh JW, Lee HB, Kim CR, Yum MK, Koh YJ, Moon SJ, Kang JO, Park IK. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma. Ann Allergy Asthma Immunol 1999; 82:491–496.
   PubMed Web of Science ®Google Scholar
• Scheicher ME, Teixeira MM, Cunha FQ, Teixeira AL Jr., Filho JT, Vianna EO. Eotaxin-2 in sputum cell culture to evaluate asthma inflammation. Eur Respir J 2007; 29(3):489–495.
   PubMedGoogle Scholar
• Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 2000; 106(3):507–513.
   PubMedGoogle Scholar
• Jinquan T, Quan S, Feili G, Larsen CG, Thestrup-Pedersen K. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4. J Immunol 1999; 162(7):4285–4292.
   PubMedGoogle Scholar
• Jahnz-Rozyk K, Plusa T, Mierzejewska J. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediators Inflamm 2000; 9(3–4):175–179.
   PubMedGoogle Scholar